Key statistics dashboard for Drugs Made In America Acquisition II Corp. (DMIIR). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Stock Data
| Price | $0.07 |
| Market Cap | $5M |
| Enterprise Value | $4.9M |
| Beta | 4.70 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 0.33 |
| Price / Book | 0.01 |
| P/S | 0.00 |
| EV/EBITDA | -3.67 |
| EV/Sales | 0.00 |
| EV/FCF | -5.09 |
| P/FCF | -4.80 |
| Earnings Yield | 390.37% |
| FCF Yield | -20.82% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 2.66% |
| Return on Assets | 2.53% |
| Return on Invested Capital | -0.28% |
| Return on Capital Employed | -0.28% |
Financial Health
| Current Ratio | 0.34 |
| Quick Ratio | 0.34 |
| Cash Ratio | 0.27 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.09% |
| Net Debt / EBITDA | -0.21 |
| Interest Coverage | 0.00 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 9.92 |
| Cash per share | 0.00 |
| FCF per share | -0.02 |
| Tangible Book Value per share | 9.92 |
| Dividend per share | 0.00 |
Explore sector: Financial Services · Financial - Conglomerates
More sections of DMIIR: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks